The metabolic syndrome - Pathogenesis, clinical features and management

dc.contributor.authorLombard L.
dc.contributor.authorAugustyn M.N.
dc.contributor.authorAscott-Evans B.H.
dc.date.accessioned2011-05-15T16:15:54Z
dc.date.available2011-05-15T16:15:54Z
dc.date.issued2002
dc.description.abstractThe metabolic syndrome is a highly prevalent clinical entity, which is often overlooked and may have far-reaching health implications for the patient. Up to 80% of patients with the metabolic syndrome die as a result of cardiovascular complications. Insulin resistance is the central component of this complex syndrome and should be appropriately addressed to ensure the best possible outcome for our patients. Recent advances in the pathogenesis and management of this syndrome is discussed in this article.
dc.description.versionReview
dc.identifier.citationCardiovascular Journal of South Africa
dc.identifier.citation13
dc.identifier.citation4
dc.identifier.issn10159657
dc.identifier.urihttp://hdl.handle.net/10019.1/13544
dc.subjectantilipemic agent
dc.subjectbeta adrenergic receptor blocking agent
dc.subjectcalcium channel blocking agent
dc.subjectdipeptidyl carboxypeptidase inhibitor
dc.subjectdiuretic agent
dc.subjectfibric acid derivative
dc.subjectfish oil
dc.subjecthydroxymethylglutaryl coenzyme A reductase inhibitor
dc.subjectmetformin
dc.subjectnicotinic acid
dc.subjectomega 3 fatty acid
dc.subjectpioglitazone
dc.subjectrosiglitazone
dc.subjectcardiovascular disease
dc.subjectclinical feature
dc.subjectdiabetes mellitus
dc.subjectdyslipidemia
dc.subjecthuman
dc.subjecthyperinsulinemia
dc.subjecthypertension
dc.subjecthyperuricemia
dc.subjectinsulin resistance
dc.subjectlifestyle
dc.subjectmetabolic disorder
dc.subjectobesity
dc.subjectpathogenesis
dc.subjectreview
dc.subjectrisk factor
dc.subjectHumans
dc.subjectMetabolic Syndrome X
dc.titleThe metabolic syndrome - Pathogenesis, clinical features and management
dc.typeReview
Files